Shipping and Logistics Considerations for Regenerative Medicine Therapies

Author:

Criswell Tracy1ORCID,Swart Corné2,Stoudemire Jana3,Brockbank Kelvin4,Floren Michael5,Eaker Shannon6,Hunsberger Joshua7

Affiliation:

1. Wake Forest Institute for Regenerative Medicine , Winston-Salem, NC , USA

2. Cellbox Solutions , Hamburg , Germany

3. Axiom Space Headquarters , Houston, TX , USA

4. Tissue Testing Technologies, LLC , Charleston, SC , USA

5. AlloSource , Centennial, CO , USA

6. Cytiva , Marlborough, MA , USA

7. Regenerative Medicine Manufacturing Society , Winston-Salem, NC , USA

Abstract

Abstract Advances in regenerative medicine manufacturing continue to be a priority for achieving the full commercial potential of important breakthrough therapies. Equally important will be the establishment of distribution chains that support the transport of live cells and engineered tissues and organs resulting from these advanced biomanufacturing processes. The importance of a well-managed distribution chain for products requiring specialized handling procedures was highlighted during the COVID-19 pandemic and serves as a reminder of the critical role of logistics and distribution in the success of breakthrough therapies. This perspective article will provide insight into current practices and future considerations for creating global distribution chains that facilitate the successful deployment of regenerative medicine therapies to the vast number of patients that would benefit from them worldwide.

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,General Medicine

Reference58 articles.

1. FDA authorizes Pfizer-BioNTech COVID-19 vaccine;Med Lett Drugs Ther.,2021

2. FDA authorizes Moderna COVID-19 vaccine;Med Lett Drugs Ther.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3